These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 14719065)

  • 1. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.
    Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG
    Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter CpG methylation of caveolin-1 in sporadic colorectal cancer.
    Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chang JG
    Anticancer Res; 2004; 24(3a):1645-50. PubMed ID: 15274335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
    Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
    Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.
    Chen ST; Lin SY; Yeh KT; Kuo SJ; Chan WL; Chu YP; Chang JG
    Int J Mol Med; 2004 Oct; 14(4):577-82. PubMed ID: 15375584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic changes in tumor suppressor genes, P15, P16, APC-3 and E-cadherin in body fluid.
    Chen ML; Chang JH; Yeh KT; Chang YS; Chang JG
    Kaohsiung J Med Sci; 2007 Oct; 23(10):498-503. PubMed ID: 18055295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
    Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
    Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
    Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
    Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
    Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.
    Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors.
    Parrella P; Poeta ML; Gallo AP; Prencipe M; Scintu M; Apicella A; Rossiello R; Liguoro G; Seripa D; Gravina C; Rabitti C; Rinaldi M; Nicol T; Tommasi S; Paradiso A; Schittulli F; Altomare V; Fazio VM
    Clin Cancer Res; 2004 Aug; 10(16):5349-54. PubMed ID: 15328171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation profile of kidney cancer.
    Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations.
    Derks S; Postma C; Carvalho B; van den Bosch SM; Moerkerk PT; Herman JG; Weijenberg MP; de Bruïne AP; Meijer GA; van Engeland M
    Carcinogenesis; 2008 Feb; 29(2):434-9. PubMed ID: 18048385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium.
    Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H
    Oncol Rep; 2008 Jan; 19(1):211-6. PubMed ID: 18097597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia.
    Tsuchiya T; Tamura G; Sato K; Endoh Y; Sakata K; Jin Z; Motoyama T; Usuba O; Kimura W; Nishizuka S; Wilson KT; James SP; Yin J; Fleisher AS; Zou T; Silverberg SG; Kong D; Meltzer SJ
    Oncogene; 2000 Jul; 19(32):3642-6. PubMed ID: 10951570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of free tumor-related DNA in the serum of breast cancer patients].
    Zhang JJ; Ouyang T; Wan WH; Deng GR
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):609-13. PubMed ID: 18210882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
    Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Promoter methylation profile in gastric cancer].
    Roa JC; Anabalón L; Roa I; Tapia O; Melo A; Villaseca M; Araya JC
    Rev Med Chil; 2005 Aug; 133(8):874-80. PubMed ID: 16163424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
    Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.